On 11 February 2026, the Birkenhead-based health technology organization Simed Global announced a strategic scientific collaboration with India’s HiMedia Laboratories to fast-track the development, assessment, and global adoption of rapid diagnostic technologies. Announced in February 2026, this collaboration remains highly relevant as global demand for rapid diagnostics accelerates.
This collaboration comes at a strategic turning point for the global diagnostics landscape, where speed, accessibility, and innovation are rapidly changing how diseases are detected and managed in a diverse healthcare framework.
Why This Partnership Matters
Simed Global brings its instant diagnostic platform to the partnership, with a focus on quick, accurate results, an asset in any pandemic preparedness plan, as well as any kind of health monitoring scenario. In Maharashtra, HiMedia Laboratories is a well-known specialist in life sciences with significant expertise in microbiology and bioscience solutions.
“By combining our instant diagnostic platform technology with HiMedia’s world-class scientific infrastructure and worldwide reach, we are taking a decisive step toward making high-quality diagnostics accessible at scale, wherever they are required most.” (Said by Simon Maurer, Simed Global founder)
India’s growing diagnostics and life sciences ecosystem makes HiMedia a perfect partner to work with. The fact that the company already has a global footprint and an extensive portfolio of products in microbial and molecular biology reagents and culture systems is an excellent starting point for quick diagnostics, R&D, and enhanced reach.
The Diagnostics Market: A Booming Opportunity
The importance of point-of-care and rapid diagnostics has significantly increased since the spread of COVID-19, with the efforts of various organisations, such as the WHO, trying to encourage technology transfer to local manufacturers in Africa and beyond.
In India, for instance, the Indian diagnostic labs market is currently valued at INR 1.54 trillion (~ USD 18.6 billion) in FY 2024 and will reach INR 2.98 trillion by FY 2030, while registering a healthy growth rate of ~11.7 % during the period of 2025-2030.
Market analysis estimates that the overall Indian market for diagnostics, such as laboratory, imaging, and devices, can grow to USD 40.1 billion by 2025 and can reach USD 124.5 billion by 2034 at a CAGR of ~12.7%.
Dr. Rajas Warke, director of molecular biology and virology at HiMedia Laboratories, said: “Rapid and reliable diagnostics are essential to modern healthcare systems.
“Our partnership with Simed Global reflects a shared commitment to scientific excellence and innovation. By working together, we aim to support the global diagnostics ecosystem with technologies that are fast, reliable, and accessible.”
Growth of Rapid Diagnostic Kits in India
In the specific segment of rapid medical diagnostic kits, the Indian market generated $657.9M in revenue in 2023. Furthermore, the revenue is expected to reach $909.3M by the year 2030, with a CAGR of ~4.7%. Rapid diagnostic tests, including those for infectious diseases and also for point-of-care applications, are seen as essential because they are simple and easy to operate.
This growth reflects the emphasis placed on decentralized and instant health screening, which is critical in the management of infectious diseases such as tuberculosis, malaria, and others.
Key Drivers of Rapid Diagnostics Demand
Several macro trends are enabling rapid diagnostics demand:
- Rising disease burden: India has over 77 million people living with diabetes, as indicated by the WHO, and this is what necessitates frequent tests for diagnosis.
- Chronic and infectious diseases: The increasing incidence of chronic diseases and the ongoing infectious disease threats have shown the need for rapid diagnosis.
- Technological advancement: The adoption of AI, molecular diagnostics, and automated lab systems is creating speed and accuracy in tests.
Strategic Implications of the Simed–HiMedia Collaboration
This partnership could help close several gaps in the current diagnostics ecosystem:
- Accelerated Validation and Regulatory Readiness
Collaborative workflows between UK tech and Indian manufacturing expertise can speed regulatory approvals across markets, a necessary step for global deployment of new diagnostic tools.
- Cost-Effective Production & Scale
India has an established and growing base of biotech manufacturing, which has the ability to manufacture products in large volumes and thereby deliver them cost-effectively. This has become more and more important, particularly in the segment of rapid diagnostic kits.
- Global Reach & Local Impact
HiMedia currently exports bioscience products to over 150 countries and utilizes its decades-long legacy. This partnership can aid in the export of quick diagnosis tools to underserved countries and increase global health security.
- Innovative Collaboration
By combining Simed Global’s instant detection technologies with HiMedia’s reagent and microbiology expertise, this partnership could produce next-generation diagnostic platforms that are faster, more accurate, and easier to use at the point of care.
Conclusion: Toward a More Resilient Healthcare Future
The collaboration between Simed Global and HiMedia Laboratories is not just a business arrangement; it’s part of their collective goal to speed up how quickly anyone with a potentially serious condition can be diagnosed around the world. These kinds of strategic collaborations can strengthen global healthcare systems, improve diagnostic access, and enhance preparedness for future health challenges. With strong growth prospects and supportive policy environments, partnerships of this kind are likely to define the next wave in healthcare innovation.
References
https://www.grandviewresearch.com/horizon/outlook/rapid-medical-diagnostic-kits-market/india